Clinical Trials in Baltimore

Showing 3041-3060 of 20,142 trials

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

NCT04997902

This phase 1/2 combination trial of tipifarnib, a farnesyltransferase inhibitor, and alpelisib, a PI3K inhibitor in participants with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) whose tumors overexpress the HRAS protein and/or are PIK3CA-mutated and/or PIK3CA-amplified.

HNSCC

Kura Oncology, Inc.45 participantsStarted Dec 2021

Duarte, California, United States • Orlando, Florida, United States • Baltimore, Maryland, United States +8 more locations

Active Not RecruitingPhase 3< 1 mile

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

Gilead Sciences500 participantsStarted Dec 2017

Little Rock, Arkansas, United States • Palo Alto, California, United States • Pasadena, California, United States +105 more locations

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

Find Trials by Condition in Baltimore

Suvorexant for Opioid/Stimulant Co-use

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

Vancomycin Reduction Practices (VRP) in the NICU

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

Ribociclib and Letrozole Treatment in Ovarian Cancer

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

SP Thoracic IDE Study

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Let's Know!2: Language-focused Intervention for Children at Risk of Comprehension Difficulties

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies